SOLX, Inc is a privately-held company headquartered in Waltham, Massachusetts. The company is an emerging leader in the management and surgical treatment of glaucoma, a leading cause of blindness in the world. Founded in 2000 by a serial ophthalmology entrepreneur, SOLX is financially-backed by MVM Life Science Partners, a leading global life science venture capital firm, and River Street Managment (RSM SOLX), an advisory and management services company.